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Abstract:  The ruthenium(II)-cymene complexes [Ru(eta(6)-cymene)(bha)Cl] with substituted 
halogenobenzohydroxamato (bha) ligands (substituents = 4-F, 4-Cl, 4-Br, 2,4-F-2, 3,4-F-2, 2,5-F-2, 2,6-F-2) 
have been synthesized and characterized by elemental analysis, IR, H-1 NMR, C-13 NMR, cyclic voltammetry 
and controlled-potential electrolysis, and density functional theory (DFT) studies. The compositions of their 
frontier molecular orbitals (MOs) were established by DFT calculations, and the oxidation and reduction 
potentials are shown to follow the orders of the estimated vertical ionization potential and electron affinity, 
respectively. The electrochemical E-L Lever parameter is estimated for the first time for the various bha 
ligands, which can thus be ordered according to their electron-donor character. All complexes exhibit very 
strong protein tyrosine kinase (PTK) inhibitory activity, even much higher than that of genistein, the clinically 
used PTK inhibitory drug. The complex containing the 2,4-difluorobenzohydroxamato ligand is the most active 
one, and the dependences of the PTK activity of the complexes and of their redox potentials on the ring 
substituents are discussed. (C) 2012 Elsevier B.V. All rights reserved. 
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